Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen's Weight Loss Result Is a Win for Eli Lilly
New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
Amgen Drug Delivers More Weight Loss Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Shares of Amgen (NASDAQ: AMGN) recently ticked lower despite a very positive-sounding press release regarding its weight management candidate. According to the giant drugmaker, treatment with an anti-obesity candidate called MariTide helped patients reduce their weight by up to 20% after 52 weeks.
MM&M
2d
Amgen’s MariTide achieves 20% weight loss, but Wall Street remains unimpressed
Amgen released the long-awaited results from its study of
weight
loss
injection
MariTide
and the results — while ...
11h
Amgen’s MariTide Phase 2 Success Drives Buy Rating Amid Promising Obesity Treatment Prospects
Goldman Sachs analyst Salveen Richter has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...
1d
AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY
Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
China releases 3 Americans
Ex-FBI informant indicted
Two-time Tony winner dies
'City under the ice'
US forces strike in Syria
Signs trans bathroom ban
No immediate 737 MAX fix
Drops lawsuit against Wood
Selected as Trump’s USTR
Fake Gibson guitars seized
Transition agreement signed
Tilson to run for NYC mayor
Retail theft operation busted
Irregular sleep effects study
Tapped as director of NEC
Suit over loss of NBA deal
Meth-soaked clothing seized
Ceasefire begins
Northern lights forecast
X claims Infowars accounts
US sanctions more allies
Man freed, gets $13M award
To restrict filters for teens
Recalling over 226K vehicles
Signs 5-yr deal w/ Dodgers?
Hawks fined $100K
Bhattacharya to lead NIH
Weekly jobless claims fall
US economy expanded
Nominees, appointees targeted
Feedback